New Delhi, Aug.29 (ANI): The New Delhi-based National Science Centre believes that the science of crystallography can be used to drive future development. In a study, the NSC described crystallography as a science that examines the arrangement of atoms or molecules, and opined that it can be applied to a wide variety of areas – from agriculture to development of cures for plant and animal …
Read the original post:
Science of crystallography can be used to drive future development: Study
Obama administration attempts to address concerns of religious employers while protecting access to birth control.
Critics take aim at new federal contraception rules
( The Translational Genomics Research Institute ) In 2012, The Ben & Catherine Ivy Foundation awarded $10 million in grants for two groundbreaking brain cancer research projects at the Translational Genomics Research Institute. One of those projects has officially received the final regulatory approval from University of California, San Francisco, which means patient enrollment for the trial can …
Sometimes, figuring out the right question is harder than finding the answer. Just ask Watson. Watson’s claim to fame rests on beating human champions in the question-and-answer game “Jeopardy!” In the three years since, IBM has been working to move Watson into the marketplace, step by step.
Questions for IBM’s Watson
University of Chicago Medicine has received state approval to build a $66.9 million outpatient center in Orland Park and spend $123.5 million to develop the third and fourth floor of its flagship hospital in Hyde Park.
Canadians are among the most scientifically literate people in the world, a new report reveals. A new report, Science Culture: Where Canada Stands, released today by the Canadian Council of Academies found that 42 per cent of Canadians have a basic level of scientific literacy necessary to understand media reports about science, putting Canada first among 35 countries with similar available data …
Amgen Inc said on Thursday it applied to U.S.
See original article:
Amgen seeks U.S. approval of new cholesterol-fighting drug